Stockholders' Equity - Summary of Additional Stock Option Disclosures (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jul. 31, 2025	Jul. 31, 2024	Jul. 31, 2023
Options Outstanding and Exercisable [Abstract]
Options Outstanding, Weighted Average Remaining Contractual Term	4 years 7 months 6 days
Options Exercisable, Weighted Average Remaining Contractual Term	4 years 6 months
Options Outstanding, Intrinsic Value	$ 26,585
Options Exercisable, Intrinsic Value	$ 25,497
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0	$ 16.41	$ 12.14
Option Exercises and Vests [Abstract]
Options, Exercised in Period, Aggregate Intrinsic Value	$ 5,559	$ 8,860	$ 1,822
Options, Vested in Period, Fair Value	1,529	2,020	3,384
Options, Exercised in Period, Proceeds from Issuance of Shares	6,171	8,186	4,091
Options Exercised, Tax Benefit	$ 1,390	$ 2,215	$ 455